CN107149660A - 一种治疗癌症的中药 - Google Patents
一种治疗癌症的中药 Download PDFInfo
- Publication number
- CN107149660A CN107149660A CN201710505483.4A CN201710505483A CN107149660A CN 107149660 A CN107149660 A CN 107149660A CN 201710505483 A CN201710505483 A CN 201710505483A CN 107149660 A CN107149660 A CN 107149660A
- Authority
- CN
- China
- Prior art keywords
- leaf
- cancer
- chinese medicine
- treatment
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 42
- 201000011510 cancer Diseases 0.000 title claims abstract description 42
- 239000003814 drug Substances 0.000 title claims abstract description 35
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 13
- 240000000249 Morus alba Species 0.000 claims abstract description 12
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 12
- 241000124033 Salix Species 0.000 claims abstract description 12
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 11
- 244000025361 Ficus carica Species 0.000 claims abstract description 9
- 235000008730 Ficus carica Nutrition 0.000 claims abstract description 9
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 9
- 241000132012 Atractylodes Species 0.000 claims abstract description 7
- 240000004307 Citrus medica Species 0.000 claims abstract description 7
- 244000241257 Cucumis melo Species 0.000 claims abstract description 7
- 235000009847 Cucumis melo var cantalupensis Nutrition 0.000 claims abstract description 7
- 244000226566 Psoralea corylifolia Species 0.000 claims abstract description 7
- 241001494508 Arundo donax Species 0.000 claims abstract description 6
- 235000014676 Phragmites communis Nutrition 0.000 claims abstract description 6
- 244000294611 Punica granatum Species 0.000 claims abstract description 6
- 235000014360 Punica granatum Nutrition 0.000 claims abstract description 6
- 240000001398 Typha domingensis Species 0.000 claims abstract description 6
- 229940079593 drug Drugs 0.000 claims abstract description 3
- 239000000463 material Substances 0.000 claims description 24
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 20
- 239000000706 filtrate Substances 0.000 claims description 12
- 241000894006 Bacteria Species 0.000 claims description 10
- 108090000790 Enzymes Proteins 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 10
- 229940088598 enzyme Drugs 0.000 claims description 10
- 238000000855 fermentation Methods 0.000 claims description 10
- 230000004151 fermentation Effects 0.000 claims description 10
- 235000014655 lactic acid Nutrition 0.000 claims description 10
- 239000004310 lactic acid Substances 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- 229940112822 chewing gum Drugs 0.000 claims description 7
- 235000015218 chewing gum Nutrition 0.000 claims description 7
- 230000001476 alcoholic effect Effects 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 230000035800 maturation Effects 0.000 claims description 5
- 238000002137 ultrasound extraction Methods 0.000 claims description 4
- 108010059892 Cellulase Proteins 0.000 claims description 3
- 244000068988 Glycine max Species 0.000 claims description 3
- 235000010469 Glycine max Nutrition 0.000 claims description 3
- 241000186673 Lactobacillus delbrueckii Species 0.000 claims description 3
- 101710084371 Lipase 7 Proteins 0.000 claims description 3
- 244000057717 Streptococcus lactis Species 0.000 claims description 3
- 235000014897 Streptococcus lactis Nutrition 0.000 claims description 3
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 229940106157 cellulase Drugs 0.000 claims description 3
- 229940059442 hemicellulase Drugs 0.000 claims description 3
- 108010002430 hemicellulase Proteins 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 230000005855 radiation Effects 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 208000024891 symptom Diseases 0.000 claims description 3
- 238000009461 vacuum packaging Methods 0.000 claims description 3
- 238000005469 granulation Methods 0.000 claims description 2
- 230000003179 granulation Effects 0.000 claims description 2
- 229920001542 oligosaccharide Polymers 0.000 claims description 2
- 150000002482 oligosaccharides Chemical class 0.000 claims description 2
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 210000004027 cell Anatomy 0.000 abstract description 5
- 230000000857 drug effect Effects 0.000 abstract description 5
- 210000002540 macrophage Anatomy 0.000 abstract description 4
- 235000008935 nutritious Nutrition 0.000 abstract description 4
- 208000019901 Anxiety disease Diseases 0.000 abstract description 2
- 230000001640 apoptogenic effect Effects 0.000 abstract description 2
- 229940126678 chinese medicines Drugs 0.000 abstract description 2
- 235000009508 confectionery Nutrition 0.000 abstract description 2
- 230000007661 gastrointestinal function Effects 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 230000003340 mental effect Effects 0.000 abstract description 2
- 230000004060 metabolic process Effects 0.000 abstract description 2
- 230000002062 proliferating effect Effects 0.000 abstract description 2
- 206010057249 Phagocytosis Diseases 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 230000008782 phagocytosis Effects 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 25
- 239000000203 mixture Substances 0.000 description 7
- 230000009286 beneficial effect Effects 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 206010006187 Breast cancer Diseases 0.000 description 3
- 208000026310 Breast neoplasm Diseases 0.000 description 3
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 3
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 3
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 3
- 208000005718 Stomach Neoplasms Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000002651 drug therapy Methods 0.000 description 3
- 206010017758 gastric cancer Diseases 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 201000007270 liver cancer Diseases 0.000 description 3
- 208000014018 liver neoplasm Diseases 0.000 description 3
- 201000005202 lung cancer Diseases 0.000 description 3
- 208000020816 lung neoplasm Diseases 0.000 description 3
- 230000018984 mastication Effects 0.000 description 3
- 238000010077 mastication Methods 0.000 description 3
- 230000036651 mood Effects 0.000 description 3
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 201000011549 stomach cancer Diseases 0.000 description 3
- 240000005809 Prunus persica Species 0.000 description 2
- 235000015111 chews Nutrition 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 235000013406 prebiotics Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- FWTBRYBHCBCJEQ-UHFFFAOYSA-N 4-[(4-phenyldiazenylnaphthalen-1-yl)diazenyl]phenol Chemical compound C1=CC(O)=CC=C1N=NC(C1=CC=CC=C11)=CC=C1N=NC1=CC=CC=C1 FWTBRYBHCBCJEQ-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- 229930192392 Mitomycin Natural products 0.000 description 1
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
- 244000134857 Typha capensis Species 0.000 description 1
- 241000385540 bacterium 10 Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000003073 embolic effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/76—Salicaceae (Willow family), e.g. poplar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明主要涉及中药领域,公开了一种治疗癌症的中药,由以下原料制成:白术、补骨脂、苍术、枳实、陈皮、青皮、益智仁、蒲黄、芦竹、桃叶、柳叶、桑叶、无花果叶、石榴花、香瓜蒂;由多种中药组成,原料广泛,价格低廉,见效快,疗程短,治愈率达到73%,有效率达到100%,减轻患者的身体及心理痛苦;多种中药进行配伍,增强药效,并经酶解和发酵,口感酸甜,淡化中药异味,减轻患者的服药痛苦,能够促进新陈代谢,增强胃肠功能,摄取均衡营养,增强免疫力,提高巨噬细胞活力,刺激机体内游走巨噬细胞的数量增长,吞噬凋亡细胞和异常增殖细胞,逐渐缩小癌灶,缓解和治疗癌症。
Description
技术领域
本发明主要涉及中药领域,尤其涉及一种治疗癌症的中药。
背景技术
随着人们生活环境的不断恶化以及生活和工作压力的不断增大,正常细胞出现了非正常增殖,导致癌症的出现,世界卫生组织报告显示,癌症的发病率以及死亡率逐年攀升,近三十年来,世界癌症发病率以年均3~5%的速度递增,目前临床普遍适用的化疗方法,效果并不理想,而且会给患者的身体和心理带来很大安定的痛苦,癌症已成为人类第一位死因,死亡率高达97%,目前少数的使用中药治疗方法,会带来明显的胃肠不适,而且疗效缓慢,疗程太长,因此,需要一种安全高效的治疗癌症的中药。
发明内容
为了弥补已有技术的缺陷,本发明的目的是提供一种治疗癌症的中药。
一种治疗癌症的中药,由以下重量份的原料制成:白术14~16、补骨脂14~16、苍术11~13、枳实11~13、陈皮11~13、青皮11~13、益智仁8~10、蒲黄8~10、芦竹8~10、桃叶8~10、柳叶5~7、桑叶5~7、无花果叶5~7、石榴花5~7、香瓜蒂5~7。
所述的桃叶,为春季新萌发的嫩叶;所述的柳叶和桑叶,为鲜绿老叶;所述的无花果叶,为秋季无花果成熟后的黄叶,含有较多的有益活性成分。
一种治疗癌症的中药的制备方法,包括以下步骤:
(1)将所有原料洗净,粉碎至60~80目,得粉碎料;
(2)向粉碎料中加入与粉碎料等重量的质量浓度为5~7%的蔗糖溶液,混合均匀,加入复合酶,使复合酶的质量浓度为0.03~0.05%,于40~42℃恒温酶解2~3小时,破坏中药的组织结构,促进活性成分释放,得酶解料;
(3)向酶解料中接入乳酸菌,使乳酸菌的质量浓度为2~4%,于37~39℃恒温发酵10~12小时,分解大分子的营养成分,产生益生物质,保护胃肠道,使患者摄入均衡营养,得发酵料;
(4)向发酵料中发酵料重量40~50倍量的水,加热煮沸至体积为原来的1/10,过滤,得一次滤液和一次滤渣;
(5)向一次滤渣中加入一次滤渣重量70~80倍量的体积分数为32~34%的酒精溶液,于30~32kHz超声提取20~25分钟,过滤,得二次滤液和二次滤渣;
(6)向二次滤渣中加入二次滤渣重量60~70倍量的体积分数为67~69%的酒精溶液,于28~30kHz超声提取20~25分钟,过滤,得三次滤液和三次滤渣;
(7)合并所有滤液和滤渣,加热浓缩至含水量为22~24%,加入所有原料重量7~9%的大豆低聚糖,搅拌至完全溶解,加入所有原料重量8~10%的口香糖胶基,造粒,经过消化道逐渐释放有益成分,增强药效,同时口香糖的咀嚼过程能够缓解患者情绪,转移患者注意力,减轻痛苦,减小心理压力,加快癌症的治愈,得治疗癌症的中药;
(8)真空包装,辐射灭菌,检验,得成品。
所述步骤(2)的复合酶,由以下重量份的酶制剂组成:纤维素酶19~21、半纤维素酶11~13、脂肪酶7~9、果胶酶3~5。
所述步骤(3)的乳酸菌,由以下重量份的菌株组成:德氏乳杆菌11~13、保加利亚乳杆菌10~12、乳酸链球菌6~8、嗜热链球菌5~7。
所述步骤(7)的颗粒,每粒重量为2g。
所述治疗癌症的中药的服用方法,每天三次,每次咀嚼2粒,15天为一个疗程,症状消失后,继续服用2~3个疗程。
本发明的优点是:本发明提供的治疗癌症的中药,由多种中药组成,原料广泛,价格低廉,见效快,疗程短,治愈率达到73%,有效率达到100%,减轻患者的身体及心理痛苦;春季新萌发的桃叶、鲜绿老柳叶和老桑叶、秋季转黄的无花果叶含有较多的有益活性成分,与多种中药进行配伍,增强药效,并经酶解、发酵和多次提取,口感酸甜,淡化中药异味,减轻患者的服药痛苦,能够促进新陈代谢,增强胃肠功能,摄取均衡营养,增强免疫力,提高巨噬细胞活力,根据病情的严重程度,刺激机体内游走巨噬细胞的数量增长,吞噬凋亡细胞和异常增殖细胞,逐渐缩小癌灶,缓解和治疗癌症;将中药制成口香糖形式进行咀嚼,经过消化道逐渐释放有益成分,增强药效,同时口香糖的咀嚼过程能够缓解患者情绪,转移患者注意力,减轻痛苦,减小心理压力,加快癌症的治愈。
具体实施方式
下面用具体实施例说明本发明。
实施例1
一种治疗癌症的中药,由以下重量份的原料制成:白术14、补骨脂14、苍术11、枳实11、陈皮11、青皮11、益智仁8、蒲黄8、芦竹8、桃叶8、柳叶5、桑叶5、无花果叶5、石榴花5、香瓜蒂5。
所述的桃叶,为春季新萌发的嫩叶;所述的柳叶和桑叶,为鲜绿老叶;所述的无花果叶,为秋季无花果成熟后的黄叶,含有较多的有益活性成分。
一种治疗癌症的中药的制备方法,包括以下步骤:
(1)将所有原料洗净,粉碎至80目,得粉碎料;
(2)向粉碎料中加入与粉碎料等重量的质量浓度为7%的蔗糖溶液,混合均匀,加入复合酶,使复合酶的质量浓度为0.04%,于40℃恒温酶解3小时,破坏中药的组织结构,促进活性成分释放,得酶解料;
(3)向酶解料中接入乳酸菌,使乳酸菌的质量浓度为3%,于38℃恒温发酵12小时,分解大分子的营养成分,产生益生物质,保护胃肠道,使患者摄入均衡营养,得发酵料;
(4)向发酵料中发酵料重量40倍量的水,加热煮沸至体积为原来的1/10,过滤,得一次滤液和一次滤渣;
(5)向一次滤渣中加入一次滤渣重量80倍量的体积分数为32%的酒精溶液,于32kHz超声提取25分钟,过滤,得二次滤液和二次滤渣;
(6)向二次滤渣中加入二次滤渣重量70倍量的体积分数为68%的酒精溶液,于30kHz超声提取20分钟,过滤,得三次滤液和三次滤渣;
(7)合并所有滤液和滤渣,加热浓缩至含水量为22~24%,加入所有原料重量9%的大豆低聚糖,搅拌至完全溶解,加入所有原料重量8%的口香糖胶基,造粒,经过消化道逐渐释放有益成分,增强药效,同时口香糖的咀嚼过程能够缓解患者情绪,转移患者注意力,减轻痛苦,减小心理压力,加快癌症的治愈,得治疗癌症的中药;
(8)真空包装,辐射灭菌,检验,得成品。
所述步骤(2)的复合酶,由以下重量份的酶制剂组成:纤维素酶19、半纤维素酶11、脂肪酶7、果胶酶3。
所述步骤(3)的乳酸菌,由以下重量份的菌株组成:德氏乳杆菌11、保加利亚乳杆菌10、乳酸链球菌6、嗜热链球菌5。
所述步骤(7)的颗粒,每粒重量为2g。
所述治疗癌症的中药的服用方法,每天三次,每次咀嚼2粒,15天为一个疗程,症状消失后,继续服用2~3个疗程。
实施例2
一种治疗癌症的中药,由以下重量份的原料制成:白术15、补骨脂15、苍术12、枳实12、陈皮12、青皮12、益智仁9、蒲黄9、芦竹9、桃叶9、柳叶6、桑叶6、无花果叶6、石榴花6、香瓜蒂6。
所述的桃叶,为春季新萌发的嫩叶;所述的柳叶和桑叶,为鲜绿老叶;所述的无花果叶,为秋季无花果成熟后的黄叶,含有较多的有益活性成分。
制备和服用方法同实施例1。
实施例3
一种治疗癌症的中药,由以下重量份的原料制成:白术16、补骨脂16、苍术13、枳实13、陈皮13、青皮13、益智仁10、蒲黄10、芦竹10、桃叶10、柳叶7、桑叶7、无花果叶7、石榴花7、香瓜蒂7。
所述的桃叶,为春季新萌发的嫩叶;所述的柳叶和桑叶,为鲜绿老叶;所述的无花果叶,为秋季无花果成熟后的黄叶,含有较多的有益活性成分。
制备和服用方法同实施例1。
对比例1
去除白术和补骨脂,其余制备和服用方法,同实施例1。
对比例2
去除苍术和枳实,其余制备和服用方法,同实施例1。
对比例3
去除陈皮、青皮和益智仁,其余制备和服用方法,同实施例1。
对比例4
去除蒲黄,其余制备和服用方法,同实施例1。
对比例5
桃叶和无花果叶均为老绿叶,其余制备和服用方法,同实施例1。
对比例6
去除香瓜蒂,其余制备和服用方法,同实施例1。
对比例7
去除步骤(2),其余制备和服用方法,同实施例1。
对比例8
去除步骤(3)中的乳酸菌,其余制备和服用方法,同实施例1。
对比例9
去除步骤(7)中的口香糖胶基,其余制备和服用方法,同实施例1。
对比例10
现有传统的丝裂霉素治疗癌症。
实施例和对比例药物治疗癌症的效果:
分别选择胃癌、肺癌、鼻咽癌、肝癌、乳腺癌、白血病患者1300人,随机分为13组,每组100人,分别为实施例组和对比例组,各组患者分别按照服用说明服用该组的药物,受试时间为1个疗程,受试前后进行检查,计算各组患者的治愈率(%),实施例和对比例药物治疗癌症的效果见表1。
表1:实施例和对比例药物治疗癌症的效果
项目 | 胃癌 | 肺癌 | 鼻咽癌 | 肝癌 | 乳腺癌 | 白血病 |
实施例1 | 68 | 63 | 71 | 67 | 70 | 64 |
实施例2 | 64 | 61 | 73 | 69 | 73 | 65 |
实施例3 | 69 | 64 | 70 | 65 | 69 | 68 |
对比例1 | 43 | 41 | 53 | 45 | 42 | 43 |
对比例2 | 41 | 39 | 51 | 47 | 43 | 47 |
对比例3 | 46 | 45 | 47 | 42 | 49 | 41 |
对比例4 | 44 | 40 | 41 | 43 | 40 | 42 |
对比例5 | 61 | 57 | 66 | 63 | 64 | 58 |
对比例6 | 51 | 49 | 53 | 48 | 51 | 47 |
对比例7 | 56 | 51 | 68 | 52 | 56 | 55 |
对比例8 | 59 | 53 | 67 | 59 | 59 | 57 |
对比例9 | 53 | 47 | 63 | 55 | 54 | 54 |
对比例10 | 0 | 0 | 0 | 0 | 0 | 0 |
从表1的结果表明,实施例的治疗癌症的中药,胃癌、肺癌、鼻咽癌、肝癌、乳腺癌、白血病的治愈率均明显较对比例高,说明本发明提供的治疗癌症的中药具有很好的治疗效果。
Claims (7)
1.一种治疗癌症的中药,其特征在于,由以下重量份的原料制成:白术14~16、补骨脂14~16、苍术11~13、枳实11~13、陈皮11~13、青皮11~13、益智仁8~10、蒲黄8~10、芦竹8~10、桃叶8~10、柳叶5~7、桑叶5~7、无花果叶5~7、石榴花5~7、香瓜蒂5~7。
2.根据权利要求1所述治疗癌症的中药,其特征在于,所述的桃叶,为春季新萌发的嫩叶;所述的柳叶和桑叶,为鲜绿老叶;所述的无花果叶,为秋季无花果成熟后的黄叶。
3.一种根据权利要求1所述治疗癌症的中药的制备方法,其特征在于,包括以下步骤:
(1)将所有原料洗净,粉碎至60~80目,得粉碎料;
(2)向粉碎料中加入与粉碎料等重量的质量浓度为5~7%的蔗糖溶液,混合均匀,加入复合酶,使复合酶的质量浓度为0.03~0.05%,于40~42℃恒温酶解2~3小时,得酶解料;
(3)向酶解料中接入乳酸菌,使乳酸菌的质量浓度为2~4%,于37~39℃恒温发酵10~12小时,得发酵料;
(4)向发酵料中发酵料重量40~50倍量的水,加热煮沸至体积为原来的1/10,过滤,得一次滤液和一次滤渣;
(5)向一次滤渣中加入一次滤渣重量70~80倍量的体积分数为32~34%的酒精溶液,于30~32kHz超声提取20~25分钟,过滤,得二次滤液和二次滤渣;
(6)向二次滤渣中加入二次滤渣重量60~70倍量的体积分数为67~69%的酒精溶液,于28~30kHz超声提取20~25分钟,过滤,得三次滤液和三次滤渣;
(7)合并所有滤液和滤渣,加热浓缩至含水量为22~24%,加入所有原料重量7~9%的大豆低聚糖,搅拌至完全溶解,加入所有原料重量8~10%的口香糖胶基,造粒,得治疗癌症的中药;
(8)真空包装,辐射灭菌,检验,得成品。
4.根据权利要求3所述治疗癌症的中药的制备方法,其特征在于,所述步骤(2)的复合酶,由以下重量份的酶制剂组成:纤维素酶19~21、半纤维素酶11~13、脂肪酶7~9、果胶酶3~5。
5.根据权利要求3所述治疗癌症的中药的制备方法,其特征在于,所述步骤(3)的乳酸菌,由以下重量份的菌株组成:德氏乳杆菌11~13、保加利亚乳杆菌10~12、乳酸链球菌6~8、嗜热链球菌5~7。
6.根据权利要求3所述治疗癌症的中药的制备方法,其特征在于,所述步骤(7)的颗粒,每粒重量为2g。
7.一种权利要求1~6任一项所述治疗癌症的中药的服用方法,其特征在于,每天三次,每次咀嚼2粒,15天为一个疗程,症状消失后,继续服用2~3个疗程。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710505483.4A CN107149660A (zh) | 2017-06-28 | 2017-06-28 | 一种治疗癌症的中药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710505483.4A CN107149660A (zh) | 2017-06-28 | 2017-06-28 | 一种治疗癌症的中药 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107149660A true CN107149660A (zh) | 2017-09-12 |
Family
ID=59795723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710505483.4A Pending CN107149660A (zh) | 2017-06-28 | 2017-06-28 | 一种治疗癌症的中药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107149660A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1273839A (zh) * | 2000-04-26 | 2000-11-22 | 济南三株药业有限公司 | 肠道益生菌发酵培养物对天然药物的转化与修饰 |
CN1546155A (zh) * | 2003-12-05 | 2004-11-17 | 刘龙光 | 一种化解和杀灭癌病的中药物 |
-
2017
- 2017-06-28 CN CN201710505483.4A patent/CN107149660A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1273839A (zh) * | 2000-04-26 | 2000-11-22 | 济南三株药业有限公司 | 肠道益生菌发酵培养物对天然药物的转化与修饰 |
CN1546155A (zh) * | 2003-12-05 | 2004-11-17 | 刘龙光 | 一种化解和杀灭癌病的中药物 |
Non-Patent Citations (1)
Title |
---|
周蓓 等: "周岱翰教授治疗恶性肿瘤验案2则", 《新中医》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1322821C (zh) | 一种纳豆粉及制备方法和含有这种纳豆粉的保健食品 | |
CN102726580B (zh) | 一种灵芝茶、灵芝袋泡茶及其加工工艺 | |
CN109480281A (zh) | 一种有机黑果枸杞酵素及其制备方法 | |
CN106165780A (zh) | 一种肉鸡用中药复合益生菌饲料添加剂及其制备方法 | |
CN106360213A (zh) | 一种黄精植物饮料及其制备方法 | |
CN114504623A (zh) | 改善气虚型便秘的中药益生菌复合制品及其制备方法 | |
CN108936628A (zh) | 一种脑卒中患者食用的特定全营养配方食品及其制备方法 | |
CN106309506B (zh) | 一种具有调经功能的益生菌组合物及其应用 | |
CN107041468A (zh) | 一种芦荟多糖饲料添加剂及其制备方法 | |
CN112515014A (zh) | 一种葛根多糖甜宗红茶及其制备方法 | |
CN102370018A (zh) | 牛蒡百合茶 | |
KR101402852B1 (ko) | 발효도라지환 및 이의 제조방법 | |
CN105943679A (zh) | 一种家禽用中药益生菌复合制剂及其制备方法 | |
CN107149660A (zh) | 一种治疗癌症的中药 | |
CN107981055A (zh) | 利用作物秸秆制备的成年羊用饲料 | |
CN103948738B (zh) | 一种具有利咽消炎作用的燕窝组合物及其制备方法和应用 | |
CN107375697B (zh) | 一种具有润肠通便的复方制剂及其制备方法和应用 | |
CN108578589B (zh) | 一种复合解酒泡腾片及其制备方法 | |
KR101093006B1 (ko) | 미생물을 이용한 우황 청심원 원료 함유 건강식품의 제조방법 및 그 제조방법에 의해 제조된 건강식품 | |
CN110859304A (zh) | 一种葵盘降嘌呤酵素及其制备方法 | |
CN116585380B (zh) | 一种用于治疗癫痫的组合物及其制备方法 | |
CN106110172A (zh) | 一种治疗牙龈出血的中药制剂 | |
CN107648392A (zh) | 用于蜜蜂疫病防治的药物组合物及其制备方法 | |
CN108379440A (zh) | 多功能饲料添加剂 | |
CN107348082A (zh) | 一种刺梨香茶及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170912 |
|
RJ01 | Rejection of invention patent application after publication |